You're not alone on the $MSTO bag. CEO Josh runs a pretty good PR campaign but it is strictly to hustle the .0001 dilution against the retail trader. It is difficult to say whether CEO Josh really gets it. At times he seems genuine and realizes some of the mistakes and others he is back on the hustle as noted. We have highlighted his mediocre results against his high life PRs - it is pretty dismal. It is wrong to lead a "public" company on a learning curve at the expense of the retail trader. There are some who would argue that is the nature of the OTC beast - but I disagree. CEO Josh along with others has a fiduciary responsibility to its' shareholders and he out right abused that role and sits in violation of his self written compensation package. We offered a gazillion suggestions over the years and not a single one was ever implemented. Oh well, let us hope the money paper trail is not too convoluted so the auditor can get thru the maze long enough to go pink, have it run, and many salvage just a bit to help their families. CEO Josh is sitting in a big home on the back of his shareholders. It is too bad many have not spoken up to let him know that. Oh well...
News 
Market Data 
Discover 
